ANI Pharmaceuticals reported $97.9M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
AbbVie USD 4.35B 344M Jun/2025
ANI Pharmaceuticals USD 97.9M 24.86M Jun/2025
Aurora Cannabis CAD 70.07M 8.78M Jun/2025
Canopy Growth CAD 54.1M 3.44M Jun/2025
Eli Lilly USD 2.45B 223.6M Jun/2025
Hikma Pharmaceutical USD 895M 82M Dec/2024
Knight Therapeutics CAD 47.25M 990K Sep/2024
Novartis USD 3.32B 5M Jun/2025
Perrigo USD 693.4M 41.8M Jun/2025
Sun Pharmaceuticals INR 28.15B 1.78B Jun/2025
Teva Pharmaceutical Industries USD 2.07B 97M Jun/2025